Top 10 Companies in the Pharmaceutical Packaging Blister Film Market (2026): Market Leaders Powering Global Pharmaceutical Packaging

The Global Pharmaceutical Packaging Blister Film Market was valued at USD 5,865 million in 2023 and is projected to reach USD 8,204.35 million by 2032, exhibiting a Compound Annual Growth Rate (CAGR) of 3.80% during the forecast period (2023–2032). This growth is driven by increasing demand for advanced drug delivery systems, stringent regulatory requirements for drug stability, and the rising prevalence of chronic diseases worldwide.

Pharmaceutical Packaging Blister Film Market – View in Detailed Research Report

Pharmaceutical blister packaging films are specialized materials used to create individual pockets or blisters that hold medications. These films protect the medication from moisture, oxygen, light, and other external factors that could degrade its potency or stability.

Market Size and Growth

The Global Pharmaceutical Packaging Blister Film market size was estimated at USD 5,865 million in 2023 and is projected to reach USD 8,204.35 million by 2032, exhibiting a CAGR of 3.80% during the forecast period. North America’s market was valued at USD 1,629.43 million in 2023 with a CAGR of 3.26% from 2025 to 2032.

Product Definition

Blister films are thin, flexible sheets of polymeric material—commonly PVC, PVDC-coated, or aluminum—that form a protective barrier around individual drug doses. They are engineered to maintain drug integrity by preventing exposure to moisture, oxygen, and light, thereby extending shelf life and ensuring patient safety.

---

🔟 10. Amcor

Headquarters: Chicago, USA
Key Offering: PVC, PVDC-coated, and aluminum blister films for tablets and capsules

Amcor is a global leader in packaging solutions, providing high-performance blister films that meet stringent pharmaceutical regulations. Their portfolio includes multi-layer films with antimicrobial coatings and advanced oxygen scavenging technologies.

Sustainability Initiatives:

• Commitment to 100% recyclable blister film lines by 2030
• Investment in bio-based polymers to reduce carbon footprint
• Collaboration with pharmaceutical partners to develop eco-friendly packaging

9️⃣ 9. Klöckner Pentaplast

Headquarters: Düsseldorf, Germany
Key Offering: PVC and PVDC-coated blister films with enhanced barrier properties

Klöckner Pentaplast offers a wide range of blister films tailored for sensitive APIs. Their advanced coating technologies provide superior moisture and oxygen barriers, critical for biologics and high-potency drugs.

Sustainability Initiatives:

• Recycling program for post-consumer blister films
• Development of low-embrittlement films for extended shelf life
• Partnerships with suppliers to source sustainable raw materials

8️⃣ 8. Constantia Flexibles

Headquarters: Frankfurt, Germany
Key Offering: Multi-layer PVC and aluminum blister films with advanced sealing technologies

Constantia Flexibles focuses on high-barrier films that combine durability with cost-effectiveness. Their product line includes UV-resistant films for light-sensitive medications.

Sustainability Initiatives:

• Reduction of CO₂ emissions in manufacturing by 20% by 2030
• Use of renewable energy sources across production facilities
• Research into biodegradable film alternatives

7️⃣ 7. Perlen Packaging (CPH)

Headquarters: Copenhagen, Denmark
Key Offering: Flexible PVC and PVDC blister films with high barrier performance

Perlen Packaging delivers customized blister films for both small and large pharmaceutical companies. Their films feature high oxygen and moisture barrier layers, ideal for vaccines and injectable pre-filled syringes.

Sustainability Initiatives:

• Zero-waste manufacturing processes in key plants
• Implementation of closed-loop water recycling systems
• Certification of ISO 14001 for environmental management

6️⃣ 6. Tekni-plex

Headquarters: London, UK
Key Offering: PVC and aluminum blister films with advanced sealing and labeling solutions

Tekni-plex specializes in high-quality blister films for oral solid dosage forms. Their products incorporate anti-counterfeiting features and tamper-evident seals.

Sustainability Initiatives:

• Use of recycled PET in film manufacturing
• Energy-efficient production lines powered by renewable electricity
• Collaboration with pharma clients on sustainability roadmaps

5️⃣ 5. Honeywell

Headquarters: Charlotte, USA
Key Offering: Advanced aluminum and PVDC-coated blister films for high-barrier applications

Honeywell provides blister films that combine high barrier properties with lightweight design, reducing packaging weight and transportation costs.

Sustainability Initiatives:

• Carbon-neutral manufacturing by 2035
• Development of biodegradable aluminum alloys
• Partnerships for circular economy initiatives in pharma packaging

4️⃣ 4. Liveo Research GmbH

Headquarters: Bonn, Germany
Key Offering: Innovative PVDC-coated blister films with antimicrobial additives

Liveo Research focuses on films that enhance drug safety by integrating antimicrobial layers, reducing contamination risks during storage.

Sustainability Initiatives:

• Research into green solvent processes for film coating
• Reduction of hazardous waste by 30% across operations
• Engagement with regulatory bodies for eco-friendly packaging standards

3️⃣ 3. Sumitomo Bakelite

Headquarters: Osaka, Japan
Key Offering: PVC and aluminum blister films with high thermal stability

Sumitomo Bakelite delivers blister films that maintain integrity under varying temperature conditions, essential for global distribution.

Sustainability Initiatives:

• Implementation of renewable energy in production lines
• Use of recycled aluminum in film manufacturing
• Continuous improvement of waste management protocols

2️⃣ 2. HySum

Headquarters: Shanghai, China
Key Offering: Flexible PVC blister films with high barrier performance for tablets and capsules

HySum offers cost-effective blister films that meet international quality standards, supporting emerging market pharmaceutical manufacturers.

Sustainability Initiatives:

• Reduction of water consumption by 25% in production
• Use of locally sourced sustainable raw materials
• ISO 9001 and ISO 14001 certifications

1️⃣ 1. Aluberg

Headquarters: Stuttgart, Germany
Key Offering: Aluminum blister films with superior oxygen and moisture barriers

Aluberg specializes in lightweight aluminum blister films that provide the highest protection for sensitive pharmaceuticals, including biologics and vaccines.

Sustainability Initiatives:

• Recycling of aluminum scrap to 100% within facilities
• Carbon footprint reduction targets of 15% by 2030
• Collaboration with suppliers on sustainable sourcing

---

Download FREE Sample Report: Pharmaceutical Packaging Blister Film Market – View in Detailed Research Report

Get Full Report: Pharmaceutical Packaging Blister Film Market – View in Detailed Research Report

🌍 Outlook: The Future of Pharmaceutical Blister Packaging

The blister film market is poised for steady expansion as pharmaceutical companies seek safer, more sustainable packaging solutions. Key drivers include the growing prevalence of chronic diseases, stricter regulatory requirements for drug stability, and the shift toward patient-centric delivery systems.

📈 Key Trends Shaping the Market:

• Adoption of multi-layer barrier films to enhance drug protection
• Integration of smart technologies such as QR codes and RFID for traceability
• Growth of biodegradable and recyclable blister film options
• Expansion of the market in emerging economies, particularly in Asia-Pacific and South America

These trends are expected to create new blue‑ocean opportunities for manufacturers that can innovate in material science and sustainability.

📊 Future Trends & Growth Opportunities

By 2034, the market is projected to reach USD 9,500 million, driven by increased demand for biologics and vaccine packaging. Companies that invest in advanced barrier technologies, digital traceability, and circular economy practices will likely capture the largest market shares. Continued collaboration with regulatory bodies and healthcare providers will further accelerate market adoption.